Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' (Deficit) Equity

v3.23.1
Consolidated Statements of Stockholders' (Deficit) Equity - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
Beginning balance at Nov. 30, 2021 $ 4,184,314 $ 146,658 $ 41,586,583 $ (20,812,734) $ (16,736,193)
Beginning balance, shares at Nov. 30, 2021   14,665,772      
Exercise of stock options 32,000 $ 100 31,900    
Exercise of stock options, shares   10,000      
Compensatory element of stock options 31,896   31,896    
Treasury stock (828,980)     (828,980)  
Net income 832,047       832,047
Ending balance at Feb. 28, 2022 4,251,277 $ 146,758 41,650,379 (21,641,714) (15,904,146)
Ending balance, shares at Feb. 28, 2022   14,675,772      
Beginning balance at Nov. 30, 2022 (1,524,302) $ 148,480 42,597,380 (22,632,649) (21,637,513)
Beginning balance, shares at Nov. 30, 2022   14,848,001      
Compensatory element of stock options 313,174   313,174    
Treasury stock (243,201)     (243,201)  
Net income 766,812       766,812
Ending balance at Feb. 28, 2023 $ (687,517) $ 148,480 $ 42,910,554 $ (22,875,850) $ (20,870,701)
Ending balance, shares at Feb. 28, 2023   14,848,001